Literature DB >> 19994907

Selective inhibition of DNA replicase assembly by a non-natural nucleotide: exploiting the structural diversity of ATP-binding sites.

Kevin Eng1, Sarah K Scouten-Ponticelli, Mark Sutton, Anthony Berdis.   

Abstract

DNA synthesis is catalyzed by an ensemble of proteins designated the replicase. The efficient assembly of this multiprotein complex is essential for the continuity of DNA replication and is mediated by clamp-loading accessory proteins that use ATP binding and hydrolysis to coordinate these events. As a consequence, the ability to selectively inhibit the activity of these accessory proteins provides a rational approach to regulate DNA synthesis. Toward this goal, we tested the ability of several non-natural nucleotides to inhibit ATP-dependent enzymes associated with DNA replicase assembly. Kinetic and biophysical studies identified 5-nitro-indolyl-2'-deoxyribose-5'-triphosphate as a unique non-natural nucleotide capable of selectively inhibiting the bacteriophage T4 clamp loader versus the homologous enzyme from Escherichia coli. Modeling studies highlight the structural diversity between the ATP-binding site of each enzyme and provide a mechanism accounting for the differences in potencies for various substituted indolyl-2'-deoxyribose-5'-triphosphates. An in vivo assay measuring plaque formation demonstrates the efficacy and selectivity of 5-nitro-indolyl-2'-deoxyribose as a cytostatic agent against T4 bacteriophage while leaving viability of the E. coli host unaffected. This strategy provides a novel approach to develop agents that selectively inhibit ATP-dependent enzymes that are required for efficient DNA replication.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19994907      PMCID: PMC3169429          DOI: 10.1021/cb900218c

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  32 in total

Review 1.  Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease.

Authors:  C Vigouroux; S Gharakhanian; Y Salhi; T H Nguyên; N Adda; W Rozenbaum; J Capeau
Journal:  Diabetes Metab       Date:  1999-11       Impact factor: 6.041

2.  Hydrophobicity, shape, and pi-electron contributions during translesion DNA synthesis.

Authors:  Xuemei Zhang; Irene Lee; Xiang Zhou; Anthony J Berdis
Journal:  J Am Chem Soc       Date:  2006-01-11       Impact factor: 15.419

3.  A potential chemotherapeutic strategy for the selective inhibition of promutagenic DNA synthesis by nonnatural nucleotides.

Authors:  Xuemei Zhang; Irene Lee; Anthony J Berdis
Journal:  Biochemistry       Date:  2005-10-04       Impact factor: 3.162

4.  Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.

Authors:  Robert A Copeland
Journal:  Methods Biochem Anal       Date:  2005

5.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 6.  Mechanisms of therapy-related carcinogenesis.

Authors:  James M Allan; Lois B Travis
Journal:  Nat Rev Cancer       Date:  2005-12       Impact factor: 60.716

7.  The use of nonnatural nucleotides to probe the contributions of shape complementarity and pi-electron surface area during DNA polymerization.

Authors:  Xuemei Zhang; Irene Lee; Anthony J Berdis
Journal:  Biochemistry       Date:  2005-10-04       Impact factor: 3.162

8.  Evaluation of human P-glycoprotein (MDR1/ABCB1) ATPase activity assay method by comparing with in vitro transport measurements: Michaelis-Menten kinetic analysis to estimate the affinity of P-glycoprotein to drugs.

Authors:  Yoshiyuki Shirasaka; Yuko Onishi; Aki Sakurai; Hiroshi Nakagawa; Toshihisa Ishikawa; Shinji Yamashita
Journal:  Biol Pharm Bull       Date:  2006-12       Impact factor: 2.233

Review 9.  Differences and evolution of the methods for the assessment of microsatellite instability.

Authors:  L Laghi; P Bianchi; A Malesci
Journal:  Oncogene       Date:  2008-08-04       Impact factor: 9.867

Review 10.  The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target.

Authors:  David N Frick
Journal:  Curr Issues Mol Biol       Date:  2007-01       Impact factor: 2.081

View more
  4 in total

1.  Evaluating the therapeutic potential of a non-natural nucleotide that inhibits human ribonucleotide reductase.

Authors:  Md Faiz Ahmad; Qun Wan; Shalini Jha; Edward Motea; Anthony Berdis; Chris Dealwis
Journal:  Mol Cancer Ther       Date:  2012-08-28       Impact factor: 6.261

2.  A novel non-natural nucleoside that influences P-glycoprotein activity and mediates drug resistance.

Authors:  Kevin T Eng; Anthony J Berdis
Journal:  Biochemistry       Date:  2010-03-02       Impact factor: 3.162

Review 3.  Architecture and conservation of the bacterial DNA replication machinery, an underexploited drug target.

Authors:  Andrew Robinson; Rebecca J Causer; Nicholas E Dixon
Journal:  Curr Drug Targets       Date:  2012-03       Impact factor: 3.465

4.  Synthetic nucleotides as probes of DNA polymerase specificity.

Authors:  Jason M Walsh; Penny J Beuning
Journal:  J Nucleic Acids       Date:  2012-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.